Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 2009
Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study
Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 4, 2010
Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy
Søren Fast, Laszlo Hegedüs, Peter Grupe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 12, 2012
Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter
Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, et al.
Danish Medical Journal
|
February 6, 2014
Substantial interobserver variation of thyroid volume and function by visual evaluation of thyroid (99m)Tc scintigraphy
Kerstin K Soelberg, Peter Grupe, Henrik Boel-Jørgensen, et al.
European Thyroid Journal
|
May 12, 2015
Systemic oxidative stress to nucleic acids is unaltered following radioiodine therapy of patients with benign nodular goiter
Steen J Bonnema, Elisabeth S Stovgaard, Søren Fast, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 18, 2013
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study
Søren Fast, Laszlo Hegedüs, Furio Pacini, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 2009
Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study
Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 4, 2010
Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy
Søren Fast, Laszlo Hegedüs, Peter Grupe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 12, 2012
Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter
Søren Fast, Viveque Egsgaard Nielsen, Peter Grupe, et al.
Danish Medical Journal
|
February 6, 2014
Substantial interobserver variation of thyroid volume and function by visual evaluation of thyroid (99m)Tc scintigraphy
Kerstin K Soelberg, Peter Grupe, Henrik Boel-Jørgensen, et al.
European Thyroid Journal
|
May 12, 2015
Systemic oxidative stress to nucleic acids is unaltered following radioiodine therapy of patients with benign nodular goiter
Steen J Bonnema, Elisabeth S Stovgaard, Søren Fast, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 18, 2013
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study
Søren Fast, Laszlo Hegedüs, Furio Pacini, et al.
Page
of 2